Back to Search
Start Over
Digital ischemia triggered by coronavirus disease 2019 in a patient under cemiplimab treatment.
- Source :
- International Journal of Dermatology; Jan2021, Vol. 60 Issue 1, pe30-e32, 3p
- Publication Year :
- 2021
-
Abstract
- Dear Editor, Cutaneous manifestations of coronavirus disease 2019 (COVID-19), including pseudo-chilblain, vesicular, maculopapular, urticaria, and livedo/necrosis1 lesions, have been widely reported. Other patients with COVID-19 and thrombotic events develop antiphospholipid antibodies, suggesting an antiphospholipid syndrome-like condition.5 Cemiplimab is a novel anti-PD-1 therapy recently approved for locally advanced or metastatic cutaneous SCC. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 00119059
- Volume :
- 60
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- International Journal of Dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 147773447
- Full Text :
- https://doi.org/10.1111/ijd.15239